Kristie Bauman

Kristie Bauman practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Kristie Bauman's NPI, 1841789450, was assigned on May 9, 2018. Kristie Bauman graduated from Lewis Katz School of Medicine in 2018. Kristie Bauman holds California license A193811.

Kristie Bauman's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Kristie Bauman's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Kristie Bauman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kristie Bauman practices, 2 sites in all. Vendor and product names are available with a free account.

Epilepsy is Kristie Bauman's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Kristie Bauman is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Kristie Bauman's licenses on file in 2 states: California and Pennsylvania.

CMS data shows 48 Medicare services from Kristie Bauman across 2 procedure codes in 2024, for 60 Medicare patients. Medicare paid $4,946 for them.

CMS counts 60 Medicare patients who saw Kristie Bauman in 2024. The largest group is 65 to 74, with 21 patients. 68% of them have high blood pressure, and 58% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kristie Bauman's median patient age at 46, with 55% women.

In 2024, Kristie Bauman wrote 154 Medicare Part D claims for 40 patients. 96% of them were for generic drugs. CMS names the drug for 101 of them, across 5 drugs with 11 or more claims each, at $5,018 in total drug cost. In 2023, CMS named 81 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Kristie Bauman for performance year 2024, reported as part of a group. Kristie Bauman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kristie Bauman as offering telehealth.

Dmand AI links 6 papers to Kristie Bauman, published from 2019 to 2023. 2021 was the busiest year, with 3. The most frequent topics are Activities of Daily Living, COVID-19 and Magnetic Resonance Imaging. Kristie Bauman has published most often in Epilepsy Behav. Kristie Bauman's most frequent co-authors are Ariane Lewis, MD, Aaron Sylvan Lord, MD and Kara Rachel Melmed, MD.

CMS Open Payments shows 5 general payments to Kristie Bauman from 4 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 55% of the total. Ceribell, Inc. paid the most, $500.

Kristie Bauman graduated from Lewis Katz School of Medicine in 2018.

Kristie Bauman is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.